Related Experiment Videos
Alginate in drug delivery systems.
Hanne Hjorth Tønnesen1, Jan Karlsen
1Institute of Pharmacy, University of Oslo, P.O. Box 1068, Blindern, 0316 Oslo, Norway.
Drug Development and Industrial Pharmacy
|August 2, 2002
Summary
Alginates are versatile biopolymers used in drug delivery for controlled release. Their unique ability to form acid and ionotropic gels offers significant potential for advanced pharmaceutical excipients.
Area of Science:
- Polymer Science
- Materials Science
- Pharmaceutical Sciences
Background:
- Alginates are versatile biopolymers with established uses in drug products, primarily for thickening, gel-forming, and stabilizing.
- The demand for controlled drug administration necessitates tailor-made polymers, with hydrocolloids like alginate playing a key role.
Purpose of the Study:
- To review the current applications and future potential of alginate as a pharmaceutical excipient in drug formulation.
- To highlight alginate's unique properties for developing controlled-release drug delivery systems.
Main Methods:
- Discussion of alginate's chemical properties, including its ability to form acid gels at low pH and ionotropic gels with divalent cations.
- Review of alginate's physical characteristics, such as bead formation and diffusion barrier properties.
- Examination of the availability of various alginate grades and salts, including ultrapure forms for implants.
Main Results:
- Alginate forms two distinct types of gels (acid and ionotropic) due to pH-dependent hydration and cation interaction, offering unique properties.
- Alginate beads create diffusion barriers, effectively controlling the migration of small molecules like drugs.
- Over 200 alginate grades are available, with potential pharmaceutical applications yet to be fully explored.
Conclusions:
- Alginate's unique gelling properties and tailor-made potential position it as a significant contributor to advanced polymeric drug delivery systems.
- The polymer's adoption by Ph.Eur. and availability in ultrapure forms support its use in pharmaceutical formulations, including implants.